Natural Products and Derivatives as Potential Zika virus Inhibitors: A Comprehensive Review. 2023

Rosângela Santos Pereira, and Françoise Camila Pereira Santos, and Priscilla Rodrigues Valadares Campana, and Vivian Vasconcelos Costa, and Rodrigo Maia de Pádua, and Daniele G Souza, and Mauro Martins Teixeira, and Fernão Castro Braga
Department of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil.

Zika virus (ZIKV) is an arbovirus whose infection in humans can lead to severe outcomes. This article reviews studies reporting the anti-ZIKV activity of natural products (NPs) and derivatives published from 1997 to 2022, which were carried out with NPs obtained from plants (82.4%) or semisynthetic/synthetic derivatives, fungi (3.1%), bacteria (7.6%), animals (1.2%) and marine organisms (1.9%) along with miscellaneous compounds (3.8%). Classes of NPs reported to present anti-ZIKV activity include polyphenols, triterpenes, alkaloids, and steroids, among others. The highest values of the selectivity index, the ratio between cytotoxicity and antiviral activity (SI = CC50/EC50), were reported for epigallocatechin gallate (SI ≥ 25,000) and anisomycin (SI ≥ 11,900) obtained from Streptomyces bacteria, dolastane (SI = 1246) isolated from the marine seaweed Canistrocarpus cervicorni, and the flavonol myricetin (SI ≥ 862). NPs mostly act at the stages of viral adsorption and internalization in addition to presenting virucidal effect. The data demonstrate the potential of NPs for developing new anti-ZIKV agents and highlight the lack of studies addressing their molecular mechanisms of action and pre-clinical studies of efficacy and safety in animal models. To the best of our knowledge, none of the active compounds has been submitted to clinical studies.

UI MeSH Term Description Entries
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071243 Zika Virus Infection A viral disease transmitted by the bite of AEDES mosquitoes infected with ZIKA VIRUS. Its mild DENGUE-like symptoms include fever, rash, headaches and ARTHRALGIA. The viral infection during pregnancy, in rare cases, is associated with congenital brain and ocular abnormalities, called Congenital Zika Syndrome, including MICROCEPHALY and may also lead to GUILLAIN-BARRE SYNDROME. Congenital Zika Syndrome,Congenital Zika Virus Infection,Fever, Zika,ZikV Infection,Zika Fever,Zika Virus Disease,Disease, Zika Virus,Infection, ZikV,Infection, Zika Virus,Virus Disease, Zika,Virus Infection, Zika
D000071244 Zika Virus An arbovirus in the FLAVIVIRUS genus of the family FLAVIVIRIDAE. Originally isolated in the Zika Forest of UGANDA it has been introduced to Asia and the Americas. Virus, Zika,ZikV
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001688 Biological Products Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay. Biologic,Biologic Drug,Biologic Product,Biological,Biological Drug,Biological Medicine,Biological Product,Biologics,Biopharmaceutical,Natural Product,Natural Products,Biologic Drugs,Biologic Medicines,Biologic Pharmaceuticals,Biologic Products,Biological Drugs,Biological Medicines,Biologicals,Biopharmaceuticals,Products, Biological,Drug, Biologic,Drug, Biological,Drugs, Biologic,Drugs, Biological,Medicine, Biological,Medicines, Biologic,Medicines, Biological,Pharmaceuticals, Biologic,Product, Biologic,Product, Biological,Product, Natural
D014709 Vero Cells A CELL LINE derived from the kidney of the African green (vervet) monkey, (CHLOROCEBUS AETHIOPS) used primarily in virus replication studies and plaque assays. Cell, Vero,Cells, Vero,Vero Cell
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications

Related Publications

Rosângela Santos Pereira, and Françoise Camila Pereira Santos, and Priscilla Rodrigues Valadares Campana, and Vivian Vasconcelos Costa, and Rodrigo Maia de Pádua, and Daniele G Souza, and Mauro Martins Teixeira, and Fernão Castro Braga
August 2020, ChemMedChem,
Rosângela Santos Pereira, and Françoise Camila Pereira Santos, and Priscilla Rodrigues Valadares Campana, and Vivian Vasconcelos Costa, and Rodrigo Maia de Pádua, and Daniele G Souza, and Mauro Martins Teixeira, and Fernão Castro Braga
November 2019, Viruses,
Rosângela Santos Pereira, and Françoise Camila Pereira Santos, and Priscilla Rodrigues Valadares Campana, and Vivian Vasconcelos Costa, and Rodrigo Maia de Pádua, and Daniele G Souza, and Mauro Martins Teixeira, and Fernão Castro Braga
May 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Rosângela Santos Pereira, and Françoise Camila Pereira Santos, and Priscilla Rodrigues Valadares Campana, and Vivian Vasconcelos Costa, and Rodrigo Maia de Pádua, and Daniele G Souza, and Mauro Martins Teixeira, and Fernão Castro Braga
January 2020, Anti-cancer agents in medicinal chemistry,
Rosângela Santos Pereira, and Françoise Camila Pereira Santos, and Priscilla Rodrigues Valadares Campana, and Vivian Vasconcelos Costa, and Rodrigo Maia de Pádua, and Daniele G Souza, and Mauro Martins Teixeira, and Fernão Castro Braga
September 2022, Medicinal research reviews,
Rosângela Santos Pereira, and Françoise Camila Pereira Santos, and Priscilla Rodrigues Valadares Campana, and Vivian Vasconcelos Costa, and Rodrigo Maia de Pádua, and Daniele G Souza, and Mauro Martins Teixeira, and Fernão Castro Braga
June 2021, RSC advances,
Rosângela Santos Pereira, and Françoise Camila Pereira Santos, and Priscilla Rodrigues Valadares Campana, and Vivian Vasconcelos Costa, and Rodrigo Maia de Pádua, and Daniele G Souza, and Mauro Martins Teixeira, and Fernão Castro Braga
October 2018, Future medicinal chemistry,
Rosângela Santos Pereira, and Françoise Camila Pereira Santos, and Priscilla Rodrigues Valadares Campana, and Vivian Vasconcelos Costa, and Rodrigo Maia de Pádua, and Daniele G Souza, and Mauro Martins Teixeira, and Fernão Castro Braga
January 2015, Journal of advanced research,
Rosângela Santos Pereira, and Françoise Camila Pereira Santos, and Priscilla Rodrigues Valadares Campana, and Vivian Vasconcelos Costa, and Rodrigo Maia de Pádua, and Daniele G Souza, and Mauro Martins Teixeira, and Fernão Castro Braga
July 2022, Pharmacological research,
Rosângela Santos Pereira, and Françoise Camila Pereira Santos, and Priscilla Rodrigues Valadares Campana, and Vivian Vasconcelos Costa, and Rodrigo Maia de Pádua, and Daniele G Souza, and Mauro Martins Teixeira, and Fernão Castro Braga
October 2019, European journal of medicinal chemistry,
Copied contents to your clipboard!